Tag: Menopause / Postmenopause
Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years
Zoledronate administered at baseline and five years effective for preventing fragility fracture, any fracture, major osteoporotic fracture
Hormone Therapy Not Associated With Glioma Risk in Women
Similar findings with no significant association seen when accounting for hormone therapy status and duration of use
Rural Women May Have Higher Burden of Menopause Symptoms
Burden greater for psychological and somatic menopause symptoms, but not vasomotor symptoms
Sexual Minority Women Report Better Sexual Functioning Than Heterosexual Women
Findings seen from a survey of female veterans in midlife
Postmenopausal Women Have Higher Risk for Developing Rheumatoid Arthritis
Risk nearly tripled for women who experience menopause before 45 years of age
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
Early Bilateral Oophorectomy Increases Risk of Alzheimer Disease
Risk even higher among women with bilateral oophorectomy carrying an APOE4 allele
Weaker Handgrip Strength Tied to Higher Likelihood of Diabetes
Findings seen among postmenopausal women; association stronger in those postmenopausal for >10 years
Tibolone, Oral Estrogen-Progestin Therapy Linked to Risk for Heart Disease
Risk for ischemic heart disease elevated for initiators of tibolone or oral estrogen-progestin therapy
No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
No long-term cognitive effects of mHT were seen in the KEEPS Continuation study, about 10 years after completion of randomized treatment
